Details

Autor(en) / Beteiligte

• Dikensoy, O
• Bayram, NG
• Erbagci, Z
• Namiduru, M
• Filiz, A
• Ekinci, E

Titel

CHURG‐STRAUSS SYNDROME IN AN HCV SEROPOSITIVE PATIENT

Ist Teil von

• International journal of clinical practice (Esher), 2003-06, Vol.57 (5), p.439-440

Ort / Verlag

Oxford: Blackwell

Erscheinungsjahr

2003

Quelle

MEDLINE

Beschreibungen/Notizen

• SUMMARY Churg‐Strauss syndrome was considered rare until leukotriene modifiers were introduced into medical practice in 1996. Since then, an increasing number of reports considering a possible relationship between leukotriene receptor antagonists and the Churg‐Strauss syndrome have been published. Hepatitis C virus (HCV) is a blood‐borne infection and a major health problem with an increasing prevalence worldwide. Previously, numerous reports suggested a relationship between HCV and certain autoimmune disorders such as cryoglobulinaemia and polyarteritis nodosa. We present a patient with HCV seropositive Churg‐Strauss syndrome and a history of systemic corticosteroid and leukotriene receptor antagonist use, and discuss the possible risk factors in the aetiology of Churg‐Strauss syndrome.